Winchester United Kingdom
April 29, 2015
Exosect, a leading provider of enabling technologies today announced the appointment of Dr. Aoife Dillon as Chief Technology Officer. Aoife joins Exosect from BASF where she was Technical Specialist for Bio-insecticides.
Aoife gained her PhD in Integrated Pest Management at the National University of Ireland and brings with her over fifteen-years of experience in bio-insecticide development and delivery of IPM strategies. She will lead the Technology Development team, overseeing all development programmes for Exosect’s licensing partners.
About Entostat
Entostat is a non-hygroscopic electrostatic micro-powder that can be produced in a range of sizes and shapes. It can be formulated into microencapsulate synthetic active ingredients offering controlled release and to support biological active ingredients on its surface by electrostatic attraction.
Entostat readily gains an electrostatic charge, consequently it adheres to a range of surfaces including, grains and seeds, insects & animals, and building fabric.
It can deliver active ingredients at a reduced application rates with equivalent or improved efficacy.
About Exosect
Exosect was launched in 2001 to develop proprietary platforms technologies, initially for agriculture. The company has developed an in-depth knowledge and extensive patent portfolio of the platforms as targeted delivery mechanisms for a range of active ingredients, biological and synthetic.
Today, the technology is enabling our partners across a range of sectors to realise the efficient delivery of their active ingredients, helping them to overcome issues such as pest resistance, regulatory controls and residues within the food chain.
Exosect is focussed on the Agriculture, Public Health and Animal Health sectors.
Topics
Species
